Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer

Cancer Research

Volumn 72, Issue 13, 2012, Pages 3135-3142

  Ho, Philip Levy ^a   Lay, Erica Julianne ^a   Jian, Weiguo ^a   Parra, Diana ^a   Chan, Keith Syson ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; NITROSAMINE; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL; BLADDER CANCER; BLADDER EPITHELIUM; CANCER GROWTH; CANCER STAGING; CARCINOMA IN SITU; CELL EXPANSION; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOGENS; DISEASE PROGRESSION; HUMANS; MICE; MICE, TRANSGENIC; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84863584311     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3195     Document Type: Article

References (23)

1. Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, et al. Focus on bladder cancer. Cancer Cell 2004;6:111-6. (Pubitemid 39485683)
2. WuXR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005;5:713-25.
3. Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 2006;24:5552-64. (Pubitemid 46631336)
4. Goebell PJ, Knowles MA. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol Oncol 2010;28:409-28.
5. Malkowicz SB, van Poppel H, Mickisch G, Pansadoro V, Thuroff J, Soloway MS, et al. Muscle-invasive urothelial carcinoma of the bladder. Urology 2007;69:3-16. (Pubitemid 46186483)
6. Cairns P, Proctor AJ, Knowles MA. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 1991;6:2305-9. (Pubitemid 21924078)
7. Hruban RH, van der Riet P, Erozan YS, Sidransky D. Brief report: molecular biology and the early detection of carcinoma of the bladder-the case of Hubert H. Humphrey. N Engl J Med 1994;330:1276-8. (Pubitemid 24129961)
8. Hartmann A, Schlake G, Zaak D, Hungerhuber E, Hofstetter A, Hofstaedter F, et al. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 2002;62:809-18. (Pubitemid 34126958)
9. Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, Wang X, Shen TH, Matos T, et al. Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev 2009;23:675-80.
10. George B, Datar RH, Wu L, Cai J, Patten N, Beil SJ, et al. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer. J Clin Oncol 2007;25:5352-8. (Pubitemid 350232209)
11. Shariat SF, Bolenz C, Karakiewicz PI, Fradet Y, Ashfaq R, Bastian PJ, et al. p53 expression in patients with advanced urothelial cancer of the urinary bladder. BJU Int 2010;105:489-95.
12. He F, Mo L, Zheng XY, Hu C, Lepor H, Lee EY, et al. Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis. Cancer Res 2009;69:9413-21.
13. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005;11:43-9. (Pubitemid 40215836)
14. Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A 2009;106:14016-21.
15. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 2007;25:2760-9. (Pubitemid 350127860)
16. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009;9:798-809.
17. Mitra AP, Pagliarulo V, Yang D, Waldman FM, Datar RH, Skinner DG, et al. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol 2009;27:3929-37.
18. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, et al. Stat3 as an oncogene. Cell 1999;98:295-303. (Pubitemid 29380565)
19. Bryan GT. The pathogenesis of experimental bladder cancer. Cancer Res 1977;37:2813-6. (Pubitemid 8160429)
20. Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A 2012;109:2078-83.
21. Chan KS, Volkmer JP, Weissman I. Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol 2010 Sep; 20393-7.
22. Zhang X, Takenaka I. Apoptosis and carcinogenesis: morphologic observations in the rat bladder treated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Int J Urol 1998;5:262-7. (Pubitemid 28302457)
23. Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol 2007;25:260-8. (Pubitemid 46670749)